[Skip to Navigation]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Navigation Landing]

December 2020 - July 1959

Decade

Year

Issue

November 2017, Vol 74, No. 11, Pages 1285-1381

In This Issue of JAMA Neurology

Highlights

Abstract Full Text
free access
JAMA Neurol. 2017;74(11):1285. doi:10.1001/jamaneurol.2016.4024
Viewpoint

The Future of the Neurologic Examination

Abstract Full Text
JAMA Neurol. 2017;74(11):1291-1292. doi:10.1001/jamaneurol.2017.2500

This Viewpoint discusses the importance of the art of the clinical examination.

On the Brain

Friday Music With Paul

Abstract Full Text
JAMA Neurol. 2017;74(11):1293. doi:10.1001/jamaneurol.2017.3009
Editorial

Which Patients With Ischemic Stroke and Insulin Resistance May Benefit From Pioglitazone Hydrochloride?

Abstract Full Text
JAMA Neurol. 2017;74(11):1294-1296. doi:10.1001/jamaneurol.2017.2142

Demystifying Neurosarcoidosis and Informing Prognosis

Abstract Full Text
JAMA Neurol. 2017;74(11):1296-1298. doi:10.1001/jamaneurol.2017.1473

Stroke Imaging: Do It Right the First Time

Abstract Full Text
JAMA Neurol. 2017;74(11):1298-1300. doi:10.1001/jamaneurol.2017.1921
Original Investigation

Prevalence of Pathogenic Copy Number Variation in Adults With Pediatric-Onset Epilepsy and Intellectual Disability

Abstract Full Text
free access
JAMA Neurol. 2017;74(11):1301-1311. doi:10.1001/jamaneurol.2017.1775

This cross-sectional study evaluates the prevalence of pathogenic copy number variations and identifies possible candidate copy number variations and genes in adults with epilepsy and intellectual disability with unknown cause.

Association of Childhood Body Mass Index and Change in Body Mass Index With First Adult Ischemic Stroke

Abstract Full Text
free access
JAMA Neurol. 2017;74(11):1312-1318. doi:10.1001/jamaneurol.2017.1627

This population-based cohort study of schoolchildren born from the 1930s through the 1980s in Denmark investigates whether childhood body mass index (BMI) and change in BMI are associated with adult ischemic stroke and assesses whether the associations are age dependent or influenced by birth weight.

Targeting Pioglitazone Hydrochloride Therapy After Stroke or Transient Ischemic Attack According to Pretreatment Risk for Stroke or Myocardial Infarction

Abstract Full Text
free access
JAMA Neurol. 2017;74(11):1319-1327. doi:10.1001/jamaneurol.2017.2136

This secondary analysis of the Insulin Resistance Intervention After Stroke trial estimates the relative and absolute effectiveness of pioglitazone after ischemic stroke or transient ischemic attack in subgroups of patients defined by pretreatment risk for stroke or myocardial infarction.

Low-Dose vs Standard-Dose Alteplase for Patients With Acute Ischemic Stroke: Secondary Analysis of the ENCHANTED Randomized Clinical Trial

Abstract Full Text
free access
JAMA Neurol. 2017;74(11):1328-1335. doi:10.1001/jamaneurol.2017.2286

This secondary analysis reports on the association of low-dose and standard-dose intravenous alteplase treatment with age, ethnicity (Asian vs non-Asian), and severity of acute ischemic stroke among patients in the ENCHANTED randomized clinical trial.

Association of Prognostic Factors and Immunosuppressive Treatment With Long-term Outcomes in Neurosarcoidosis

Abstract Full Text
free access
JAMA Neurol. 2017;74(11):1336-1344. doi:10.1001/jamaneurol.2017.2492

This cohort study identifies prognostic factors for immunosuppressive treatment in patients with neurosarcoidosis and assesses the association of such treatment with relapse of the disease.

Trends in Dementia Incidence in a Birth Cohort Analysis of the Einstein Aging Study

Abstract Full Text
free access
JAMA Neurol. 2017;74(11):1345-1351. doi:10.1001/jamaneurol.2017.1964

This birth cohort study examined trends in dementia incidence and concomitant trends in cardiovascular comorbidities among individuals aged 70 years or older who were enrolled in the Einstein Aging Study between 1993 and 2015.

Survival End Points for Huntington Disease Trials Prior to a Motor Diagnosis

Abstract Full Text
free access
JAMA Neurol. 2017;74(11):1352-1360. doi:10.1001/jamaneurol.2017.2107

This study uses data from the Track and COHORT studies to examine an approach to planning prediagnosis clinical trials for Huntington disease.

Clinical Imaging Factors Associated With Infarct Progression in Patients With Ischemic Stroke During Transfer for Mechanical Thrombectomy

Abstract Full Text
free access
JAMA Neurol. 2017;74(11):1361-1367. doi:10.1001/jamaneurol.2017.2149

This cohort study examines the clinical imaging factors associated with unfavorable imaging profile evolution for thrombectomy in patients with ischemic stroke initially transferred to non–thrombectomy-capable stroke centers.

Optic Nerve Infiltration in Primary Central Nervous System Lymphoma

Abstract Full Text
free access
JAMA Neurol. 2017;74(11):1368-1373. doi:10.1001/jamaneurol.2017.2545

This case series describes the clinical presentation of optic nerve infiltration, its imaging characteristics, and outcomes in patients with primary central nervous system lymphomas.

Images in Neurology

Infectious Pneumorrhachis Due to Emphysematous Pyelonephritis

Abstract Full Text
JAMA Neurol. 2017;74(11):1374-1375. doi:10.1001/jamaneurol.2017.2340

This case report describes the association between emphysematous pyelonephritis and infectious pneumorrhachis.

Research Letter

Risk of Tinnitus After Medial Temporal Lobe Surgery

Abstract Full Text
free access
JAMA Neurol. 2017;74(11):1376-1377. doi:10.1001/jamaneurol.2017.2718

This study compares the prevalence of tinnitus among patients who underwent medial temporal lobe resection, matched controls, and individuals with self-reported epilepsy to determine whether medial temporal lobe removal is associated with tinnitus.

Comment & Response

Mild Traumatic Brain Injury and Mental Health

Abstract Full Text
JAMA Neurol. 2017;74(11):1377-1378. doi:10.1001/jamaneurol.2017.2768

Mild Traumatic Brain Injury and Mental Health—Reply

Abstract Full Text
JAMA Neurol. 2017;74(11):1378. doi:10.1001/jamaneurol.2017.2771

Overall Survival and Causes of Death in Neurodegeneration—An Overlooked and Underreported Theme

Abstract Full Text
JAMA Neurol. 2017;74(11):1379. doi:10.1001/jamaneurol.2017.2862

Overall Survival and Causes of Death in Neurodegeneration—An Overlooked and Underreported Theme—Reply

Abstract Full Text
JAMA Neurol. 2017;74(11):1379-1380. doi:10.1001/jamaneurol.2017.2877

Dual-Task Gait and Incident Dementia: A Step Forward, but Not There Yet

Abstract Full Text
JAMA Neurol. 2017;74(11):1380. doi:10.1001/jamaneurol.2017.2874

Dual-Task Gait And Incident Dementia—A Step Forward, But Not There Yet—Reply

Abstract Full Text
JAMA Neurol. 2017;74(11):1380-1381. doi:10.1001/jamaneurol.2017.2880
Correction

Error in Discussion Section

Abstract Full Text
free access
JAMA Neurol. 2017;74(11):1381. doi:10.1001/jamaneurol.2017.2722
JAMA Neurology Masthead

JAMA Neurology

Abstract Full Text
free access
JAMA Neurol. 2017;74(11):1288. doi:10.1001/jamaneurol.2016.4025
×